Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.

Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection

NCT05585684 ·Status: RECRUITING

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444 ·Status: RECRUITING

Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas

NCT04224064 ·Status: RECRUITING ·Phase: NA

Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC

NCT03302325 ·Status: COMPLETED

PRecision Oncology Evidence Development in Cancer Treatment - Liquid

NCT05057234 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation

NCT03553550 ·Status: TERMINATED

A Study to Evaluate the Impact of Liquid Biopsy in Participants With a Clinical Diagnosis of Advanced Cancer

NCT05846594 ·Status: COMPLETED ·Phase: NA

Implementing Precision Medicine in cOmmunity HospiTALs

NCT05283044 ·Status: RECRUITING ·Phase: NA

Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies

NCT05275036 ·Status: UNKNOWN

Versatile Ampification Single-Molecule Detection in Liquid Biopsy

NCT05940311 ·Status: RECRUITING

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

NCT07327489 ·Status: RECRUITING

Liquid Micro-biopsy: a Novel Approach to Study Tumor Microenvironment From the Peripheral Blood

NCT06764589 ·Status: ACTIVE_NOT_RECRUITING

Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.

NCT05083494 ·Status: UNKNOWN

Biology Studies of Hematologic Cancers

NCT00923442 ·Status: ENROLLING_BY_INVITATION

Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer

NCT02245100 ·Status: COMPLETED

Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy

NCT06290856 ·Status: TERMINATED

Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)

NCT05099068 ·Status: UNKNOWN ·Phase: NA

Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA

NCT06606366 ·Status: RECRUITING ·Phase: NA

Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer

NCT05032092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069 ·Status: RECRUITING

Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity

NCT05791149 ·Status: RECRUITING ·Phase: NA

Use of a Liquid Biopsy Signature to Detect Early-onset Gastric Cancer

NCT06023121 ·Status: COMPLETED

Liquid Biopsy in Head and Neck Cancer

NCT03926468 ·Status: UNKNOWN

Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing

NCT04213326 ·Status: COMPLETED

Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer

NCT00491621 ·Status: TERMINATED ·Phase: NA